Population Health Sciences

You are here

Home > Publications > Publications

Publications

Found 289 results
Author Title [ Type(Asc)] Year
Filters: First Letter Of Last Name is C  [Clear All Filters]
Journal Article
Berg AT, Wusthoff C, Shellhaas RA, Loddenkemper T, Grinspan ZM, Saneto RP, Knupp KG, Patel A, Sullivan JE, Kossoff EH et al..  2019.  Immediate outcomes in early life epilepsy: A contemporary account.. Epilepsy Behav. 97:44-50.
Berg AT, Wusthoff C, Shellhaas RA, Loddenkemper T, Grinspan ZM, Saneto RP, Knupp KG, Patel A, Sullivan JE, Kossoff EH et al..  2019.  Immediate outcomes in early life epilepsy: A contemporary account.. Epilepsy Behav. 97:44-50.
Xu Z, Chou J, Zhang XSheryl, Luo Y, Isakova T, Adekkanattu P, Ancker JS, Jiang G, Kiefer RC, Pacheco JA et al..  2020.  Identifying sub-phenotypes of acute kidney injury using structured and unstructured electronic health record data with memory networks.. J Biomed Inform. 102:103361.
Zhang Y, Hu H, Fokaidis V, V CLewis, Xu J, Zang C, Xu Z, Wang F, Koropsak M, Bian J et al..  2023.  Identifying environmental risk factors for post-acute sequelae of SARS-CoV-2 infection: An EHR-based cohort study from the recover program.. Environ Adv. 11:100352.
Zang C, Hou Y, Schenck EJ, Xu Z, Zhang Y, Xu J, Bian J, Morozyuk D, Khullar D, Nordvig AS et al..  2024.  Identification of risk factors of Long COVID and predictive modeling in the RECOVER EHR cohorts.. Commun Med (Lond). 4(1):130.
Su C, Hou Y, Xu J, Xu Z, Zhou M, Ke A, Li H, Xu J, Brendel M, Maasch JRMA et al..  2024.  Identification of Parkinson's disease PACE subtypes and repurposing treatments through integrative analyses of multimodal data.. NPJ Digit Med. 7(1):184.
Su C, Hou Y, Xu J, Xu Z, Zhou M, Ke A, Li H, Xu J, Brendel M, Maasch JRMA et al..  2024.  Identification of Parkinson's disease PACE subtypes and repurposing treatments through integrative analyses of multimodal data.. NPJ Digit Med. 7(1):184.
Su C, Hou Y, Xu J, Xu Z, Zhou M, Ke A, Li H, Xu J, Brendel M, Maasch JRMA et al..  2024.  Identification of Parkinson's disease PACE subtypes and repurposing treatments through integrative analyses of multimodal data.. NPJ Digit Med. 7(1):184.
Alfonso D, Cabrera LY, Sidiropoulos C, Wang F, Sarva H.  2022.  How Parkinson's patients in the USA perceive deep brain stimulation in the 21st century: Results of a nationwide survey.. J Clin Neurosci. 95:20-26.
McIntire PJ, Zhong E, Patel A, Khani F, D'Alfonso TM, Chen Z, Shin SJ, Ginter PS.  2019.  Hotspot enumeration of CD8+ tumor-infiltrating lymphocytes using digital image analysis in triple-negative breast cancer yields consistent results.. Hum Pathol. 85:27-32.
Lohman MC, Cotton BP, Zagaria AB, Bao Y, Greenberg RL, Fortuna KL, Bruce ML.  2017.  Hospitalization Risk and Potentially Inappropriate Medications among Medicare Home Health Nursing Patients.. J Gen Intern Med. 32(12):1301-1308.
Scali ST, Beck AW, Sedrakyan A, Mao J, Venermo M, Faizer R, Schermerhorn M, Beiles B, Szeberin Z, Eldrup N et al..  2019.  Hospital Volume Association With Abdominal Aortic Aneurysm Repair Mortality: Analysis of the International Consortium of Vascular Registries.. Circulation. 140(15):1285-1287.
Scali ST, Beck AW, Sedrakyan A, Mao J, Venermo M, Faizer R, Schermerhorn M, Beiles B, Szeberin Z, Eldrup N et al..  2019.  Hospital Volume Association With Abdominal Aortic Aneurysm Repair Mortality: Analysis of the International Consortium of Vascular Registries.. Circulation. 140(15):1285-1287.
Gomez-Arteaga A, Mark TM, Guarneri D, Christos PJ, Gergis U, Greenberg JD, Hsu J, Mayer SA, Niesvizky R, Pearse RN et al..  2019.  High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myeloma.. Bone Marrow Transplant.
Gomez-Arteaga A, Mark TM, Guarneri D, Christos PJ, Gergis U, Greenberg JD, Hsu J, Mayer SA, Niesvizky R, Pearse RN et al..  2019.  High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myeloma.. Bone Marrow Transplant.
Kern LM, Seirup JK, Casalino LP, Safford MM.  2017.  Healthcare Fragmentation and the Frequency of Radiology and Other Diagnostic Tests: A Cross-Sectional Study.. J Gen Intern Med. 32(2):175-181.
Kern LM, Rajan M, Pincus HA, Casalino LP, Stuard SS.  2019.  Health Care Fragmentation in Medicaid Managed Care vs. Fee-for-Service.. Popul Health Manag.
Liu J, van der Smissen WJCPrager, J Collée M, Bolla MK, Wang Q, Michailidou K, Dennis J, Ahearn TU, Aittomäki K, Ambrosone CB et al..  2020.  Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.. Sci Rep. 10(1):9688.
Liu J, van der Smissen WJCPrager, J Collée M, Bolla MK, Wang Q, Michailidou K, Dennis J, Ahearn TU, Aittomäki K, Ambrosone CB et al..  2020.  Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.. Sci Rep. 10(1):9688.
Liu J, van der Smissen WJCPrager, J Collée M, Bolla MK, Wang Q, Michailidou K, Dennis J, Ahearn TU, Aittomäki K, Ambrosone CB et al..  2020.  Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.. Sci Rep. 10(1):9688.
Liu J, van der Smissen WJCPrager, J Collée M, Bolla MK, Wang Q, Michailidou K, Dennis J, Ahearn TU, Aittomäki K, Ambrosone CB et al..  2020.  Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.. Sci Rep. 10(1):9688.
Liu J, van der Smissen WJCPrager, J Collée M, Bolla MK, Wang Q, Michailidou K, Dennis J, Ahearn TU, Aittomäki K, Ambrosone CB et al..  2020.  Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.. Sci Rep. 10(1):9688.
Liu J, van der Smissen WJCPrager, J Collée M, Bolla MK, Wang Q, Michailidou K, Dennis J, Ahearn TU, Aittomäki K, Ambrosone CB et al..  2020.  Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.. Sci Rep. 10(1):9688.
Liu J, van der Smissen WJCPrager, J Collée M, Bolla MK, Wang Q, Michailidou K, Dennis J, Ahearn TU, Aittomäki K, Ambrosone CB et al..  2020.  Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.. Sci Rep. 10(1):9688.
Liu J, van der Smissen WJCPrager, J Collée M, Bolla MK, Wang Q, Michailidou K, Dennis J, Ahearn TU, Aittomäki K, Ambrosone CB et al..  2020.  Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.. Sci Rep. 10(1):9688.